Masalu uzliesmojums Latvij\u0101 pieaug<\/p>\n
Latvij\u0101 turpin\u0101s masalu uzliesmojums, un l\u012bdz \u0161im re\u0123istr\u0113ti jau 37 saslimu\u0161ie, liecina Slim\u012bbu profilakses un kontroles centra (SPKC) publiskot\u0101 inform\u0101cija. K\u0101 inform\u0113 port\u0101ls jauns.lv, p\u0113d\u0113j\u0101 laik\u0101 saslimis v\u0113l viens b\u0113rns, palielinot infic\u0113to skaitu. Kopum\u0101 ar masal\u0101m saslimu\u0161i 13 b\u0113rni vecum\u0101 no se\u0161iem l\u012bdz desmit gadiem, 13 b\u0113rni vecum\u0101 no 11 l\u012bdz 15 gadiem, k\u0101 ar\u012b viens jaunietis vecum\u0101 no 16 l\u012bdz 20 gadiem. P\u0101r\u0113jie saslimu\u0161ie ir pieaugu\u0161ie, kuru vecums sv\u0101rst\u0101s no 31 l\u012bdz 55 gadiem.<\/p>\n
Liel\u0101k\u0101 da\u013ca saslimu\u0161o ir R\u012bgas Valdorfskolas audz\u0113k\u0146i, kas nor\u0101da uz \u0161\u012bs izgl\u012bt\u012bbas iest\u0101des noz\u012bm\u012bgo lomu uzliesmojuma izplat\u012bb\u0101. SPKC uzsver, ka infic\u0113\u0161an\u0101s risks, \u012bpa\u0161i nevakcin\u0113to personu vid\u016b, joproj\u0101m ir augsts, jo nav iesp\u0113jams apzin\u0101t visas kontaktpersonas, \u012bpa\u0161i gad\u012bjuma kontaktus publisk\u0101s viet\u0101s.<\/p>\n
Masalas \u2013 \u013coti lip\u012bga un b\u012bstama slim\u012bba<\/p>\n
Masalas ir ak\u016bta, \u013coti lip\u012bga v\u012brusu infekcijas slim\u012bba, kas izplat\u0101s gaisa pilienu veid\u0101. Tas noz\u012bm\u0113, ka infic\u0113\u0161an\u0101s iesp\u0113jama ne tikai tie\u0161\u0101 kontakt\u0101 ar slimnieku, bet ar\u012b uzturoties telp\u0101s, kur\u0101s masalu slimnieks atradies p\u0113d\u0113jo divu stundu laik\u0101. Slim\u012bbas inkub\u0101cijas periods ir no 7 l\u012bdz 18 dien\u0101m. Simptomi s\u0101kotn\u0113ji atg\u0101dina saaukst\u0113\u0161anos \u2013 drudzis, iesnas, klepus, acu aps\u0101rtums un jut\u012bgums pret gaismu. V\u0113l\u0101k par\u0101d\u0101s rakstur\u012bgi sarkani izsitumi, kas izplat\u0101s no galvas uz \u0137ermeni.<\/p>\n
Lai gan masalas bie\u017ei norit viegli, t\u0101s var rad\u012bt ar\u012b smagas komplik\u0101cijas. Visbie\u017e\u0101k\u0101s komplik\u0101cijas ir vidusauss iekaisums, caureja un pneimonija. Aptuveni viens no 1000 masalu pacientiem var saslimt ar encefal\u012btu jeb smadze\u0146u iekaisumu. \u012apa\u0161s risks past\u0101v b\u0113rniem l\u012bdz piecu gadu vecumam, pieaugu\u0161ajiem virs 20 gadiem, person\u0101m ar im\u016bndefic\u012btu un gr\u016btniec\u0113m.<\/p>\n
Vakcin\u0101cija \u2013 vien\u012bg\u0101 efekt\u012bv\u0101 profilakse<\/p>\n
SPKC aicina vec\u0101kus un \u0123imenes \u0101rstus p\u0101rbaud\u012bt b\u0113rnu vakcin\u0101cijas statusu. Saska\u0146\u0101 ar vakcin\u0101cijas kalend\u0101ru, pirm\u0101 vakcin\u0101cija pret masal\u0101m j\u0101veic 12\u201315 m\u0113ne\u0161u vecum\u0101, bet revakcin\u0101cija \u2013 septi\u0146u gadu vecum\u0101. Ja vakcin\u0101cija nav veikta savlaic\u012bgi, person\u0101m ir iesp\u0113ja to sa\u0146emt k\u0101 valsts apmaks\u0101tu pakalpojumu l\u012bdz 25 gadu vecumam.<\/p>\n
Lai nodro\u0161in\u0101tu kolekt\u012bvo imunit\u0101ti un nov\u0113rstu uzliesmojumus, nepiecie\u0161ams, lai vismaz 95% popul\u0101cijas b\u016btu vakcin\u0113ti. Latvij\u0101 ir nodro\u0161in\u0101tas valsts apmaks\u0101tas vakcin\u0101cijas iesp\u0113jas, tom\u0113r aptuveni 14 000 b\u0113rnu vecum\u0101 no 1 l\u012bdz 17 gadiem nav sa\u0146\u0113mu\u0161i nevienu poti pret masal\u0101m, kas rada b\u016btisku risku infekcijas izplat\u012bbai.<\/p>\n
Epidemiolo\u0123isk\u0101 situ\u0101cija un riski<\/p>\n
Lai gan Latvija agr\u0101k ir bijusi valsts, kur\u0101 masalu v\u012brusa transmisija ir p\u0101rtraukta, p\u0113d\u0113jie uzliesmojumi liecina par izmai\u0146\u0101m \u0161aj\u0101 situ\u0101cij\u0101. 2014. gad\u0101 Latvij\u0101 tika re\u0123istr\u0113ti 36 saslim\u0161anas gad\u012bjumi, bet 2018. gad\u0101 \u2013 25 gad\u012bjumi. P\u0113c tam l\u012bdz 2025. gadam bija tikai divi gad\u012bjumi, ta\u010du tagad nov\u0113rojams strauj\u0161 saslimst\u012bbas pieaugums.<\/p>\n
Infekcijas turpm\u0101k\u0101s izplat\u012b\u0161an\u0101s risks, \u012bpa\u0161i nevakcin\u0113to personu vid\u016b, tiek v\u0113rt\u0113ts k\u0101 augsts. Nav iesp\u0113jams apzin\u0101t visas kontaktpersonas, sevi\u0161\u0137i gad\u012bjuma kontaktus publiskaj\u0101s viet\u0101s, kas v\u0113l vair\u0101k palielina uzliesmojuma izplat\u012b\u0161an\u0101s potenci\u0101lu. SPKC uzsver, ka ikvienam, kam par\u0101d\u0101s masal\u0101m rakstur\u012bgas paz\u012bmes, ir svar\u012bgi palikt m\u0101j\u0101s, sazin\u0101ties ar \u0101rstu un r\u016bp\u012bgi iev\u0113rot vi\u0146a nor\u0101d\u012bjumus.<\/p>\n","protected":false},"excerpt":{"rendered":"Masalu uzliesmojums Latvij\u0101 pieaug Latvij\u0101 turpin\u0101s masalu uzliesmojums, un l\u012bdz \u0161im re\u0123istr\u0113ti jau 37 saslimu\u0161ie, liecina Slim\u012bbu profilakses…\n","protected":false},"author":2,"featured_media":169937,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[5],"tags":[23,28,29,32,33,22,30,31,35,39,38,36,37,34,40,31683,20,26,27,1580,24,25,10780,7873,21],"class_list":["post-169936","post","type-post","status-publish","format-standard","has-post-thumbnail","category-aktualitates","tag-aktualitates","tag-breaking-news","tag-breakingnews","tag-featured-news","tag-featurednews","tag-headlines","tag-latest-news","tag-latestnews","tag-latvia","tag-latvian","tag-latviesu","tag-latviesu-valoda","tag-latviesuvaloda","tag-latvija","tag-lv","tag-masalas","tag-news","tag-popularakas-zinas","tag-popularakaszinas","tag-spkc","tag-top-stories","tag-topstories","tag-uzliesmojums","tag-vakcinacija","tag-zinas"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@lv\/116336504531404522","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/posts\/169936","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/comments?post=169936"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/posts\/169936\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/media\/169937"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/media?parent=169936"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/categories?post=169936"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/tags?post=169936"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}